News
News releases on May 11, 2023, page 5
Every news release public companies put out on May 11, 2023 (UTC): 716 news releases, newest first. Open any release to read it.
Reborn Coffee Reports First Quarter 2023 Financial Results
Reborn Coffee, Inc. · May 11, 2023
Rasmussen University Announces 2023 Nursing Excellence Award Winners
American Public Education, Inc. · May 11, 2023
Rail Vision Ltd. Announces Closing of Registered Direct and Private Placements
Rail Vision Ltd. · May 11, 2023
Quantum-Si Reports First Quarter 2023 Financial Results
Quantum-Si Incorporated · May 11, 2023
Quantum Computing Inc Announces First Quarter 2023 Financial Results
Quantum Computing Inc. · May 11, 2023
Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
Pyxis Oncology, Inc. · May 11, 2023
Puma Exploration Closes Private Placement Offerings for Gross Proceeds of $1,008,035
Puma Exploration Inc. · May 11, 2023
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
Pulse Biosciences, Inc · May 11, 2023
Protagonist Therapeutics to Participate in the JMP Securities Life Sciences Conference
Protagonist Therapeutics, Inc. · May 11, 2023
Protagonist Therapeutics Announces Presentations at the 2023 Annual Congress of the European Hematology Association
Protagonist Therapeutics, Inc. · May 11, 2023
ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights
ProKidney Corp. · May 11, 2023
Prismo Metals Commences Drill Program at Palos Verdes
Prismo Metals Inc. · May 11, 2023
Priority Technology Holdings, Inc. Announces First Quarter 2023 Financial Results
Priority Technology Holdings, Inc. · May 11, 2023
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2023 Financial Results
Praxis Precision Medicines, Inc. · May 11, 2023
Praxis Precision Medicines Announces Positive Topline Results from PRAX-628 Phase 1 Study Enabling Best-in-Class Profile
Praxis Precision Medicines, Inc. · May 11, 2023
Power Solutions International Announces First Quarter 2023 Financial Results
Power Solutions International, Inc. · May 11, 2023
POET Technologies Announces First Volume Purchase Order For Its Optical Engines
POET Technologies Inc. · May 11, 2023
Phunware Reports First Quarter 2023 Financial Results
Phunware, Inc. · May 11, 2023
Phio Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
Phio Pharmaceuticals Corp. · May 11, 2023
PhenixFIN Corporation Announces Fiscal Second Quarter 2023 Financial Results
PhenixFIN Corporation · May 11, 2023
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
PharmaCyte Biotech, Inc. · May 11, 2023
PepGen Reports First Quarter 2023 Financial Results and Recent Corporate Developments
PepGen Inc. · May 11, 2023
Peoples Financial Services Corp. announces restart of common stock repurchase plan
Peoples Financial Services Corp. · May 11, 2023
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
Passage Bio, Inc. · May 11, 2023
Palisade Bio Announces Enrollment and Dosing of First Patient in LB1148 Dose Optimization Study
Palisade Bio, Inc. · May 11, 2023
Ouster Exceeds Q1 2023 Revenue Guidance; Increases Target for Merger Cost Synergies
Ouster, Inc. · May 11, 2023
Ouster Awarded Production Win by Motional to be the Exclusive Supplier of Long-Range Lidar for its Autonomous Vehicles
Ouster, Inc. · May 11, 2023
OSS Reports Q1 2023 Results
One Stop Systems, Inc. · May 11, 2023
Orla Mining Reports Strong Start to Year in First Quarter 2023 Results; Agnico Eagle Mines Exercises Top-Up Right
Orla Mining Ltd. · May 11, 2023
OmniAb Reports First Quarter 2023 Financial Results and Business Highlights
OmniAb, Inc. · May 11, 2023
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
Olema Pharmaceuticals, Inc. · May 11, 2023
Oculis Co-founders Selected as Finalists in European Inventor Award 2023
Oculis Holding AG · May 11, 2023
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Re...
Nuvalent, Inc. · May 11, 2023
Nutanix Announces Date and Conference Call Information for Third Quarter Fiscal Year 2023 Financial Results
Nutanix, Inc. · May 11, 2023
Nova Reports First Quarter 2023 Results
Nova Ltd. · May 11, 2023
Nkarta to Present NKX019 Phase 1 Dose Escalation Data at European Hematology Association 2023 Congress and 17th International Conference ...
Nkarta, Inc. · May 11, 2023
Nkarta Reports First Quarter 2023 Financial Results and Corporate Highlights
Nkarta, Inc. · May 11, 2023
NioCorp Announces Delay in Filing Quarterly Financial Statements
NioCorp Developments Ltd. · May 11, 2023
New Summer Area Rug Collection from FLOR Embraces Themes of the Season
Interface, Inc. · May 11, 2023
News Corporation Reports Third Quarter Results for Fiscal 2023
News Corporation · May 11, 2023
New Energy Metals Provides Technical Update on Troitsa Copper Project and Files NI 43-101 Technical Report
New Energy Metals Corp. · May 11, 2023
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
NeuroOne Medical Technologies Corporation · May 11, 2023
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation · May 11, 2023
NETSOL Technologies Reports Fiscal Third Quarter 2023 Financial Results
NETSOL Technologies Inc. · May 11, 2023
Neonode Reports Quarter Ended March 31, 2023 Financial Results
Neonode Inc. · May 11, 2023
NEO Battery Materials to Conduct Additional Optimized Evaluations with Global Battery Manufacturers & EV Automakers and Files Two Key Sil...
NEO Battery Materials Ltd · May 11, 2023
National Vision Holdings, Inc. Reports First Quarter 2023 Financial Results
National Vision Holdings, Inc. · May 11, 2023
National MI Celebrates 10th Anniversary of IPO by Ringing Closing Bell at NASDAQ
NMI Holdings Inc · May 11, 2023
Mustang Bio Announces Upcoming Presentations of Clinical Data from Phase 1/2 Trial of MB-106, a CD20-Targeted Autologous CAR T Cell Therapy
Mustang Bio, Inc. · May 11, 2023
Motorsport Games Reports First Quarter 2023 Financial Results
Motorsport Games Inc. · May 11, 2023
Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
Monte Rosa Therapeutics, Inc. · May 11, 2023
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments
Monopar Therapeutics Inc. · May 11, 2023
Momentus Inc. Announces First Quarter 2023 Financial Results
Momentus Inc. · May 11, 2023
Moleculin Reports First Quarter 2023 Financial Results
Moleculin Biotech, Inc. · May 11, 2023
Mo, an AI Chatbot Powered by Morningstar Intelligence Engine, Debuts in Morningstar Platforms
Morningstar, Inc. · May 11, 2023
Mirum Pharmaceuticals Announces Enrollment Completion in Phase 2b EMBARK Biliary Atresia Study
Mirum Pharmaceuticals, Inc. · May 11, 2023
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
MiNK Therapeutics, Inc. · May 11, 2023
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update
Milestone Pharmaceuticals Inc. · May 11, 2023
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
MeiraGTx Holdings plc · May 11, 2023
Medalist Diversified REIT, Inc. Reports First Quarter 2023 Financial Results
Medalist Diversified, Inc. · May 11, 2023
MarketWise Reports Financial Results for First Quarter 2023
MarketWise, Inc. · May 11, 2023
MarketWise Announces Initiation of Quarterly Cash Dividend
MarketWise, Inc. · May 11, 2023
Manning Ventures Annouces Upcoming Field Program at the Newfoundland Dipole Lithium Property
Manning Ventures Inc · May 11, 2023
Manhattan Associates Named a Leader in Gartner® Magic Quadrant™ for WMS for the Fifteenth Consecutive Time
Manhattan Associates, Inc. · May 11, 2023
Mangoceuticals Launches New “Some Things Are Better Hard” Viral Video Ad Campaign
Mangoceuticals, Inc. · May 11, 2023
Madrigal Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
Madrigal Pharmaceuticals, Inc. · May 11, 2023
Lulus to Participate in Upcoming Investor Conferences
Lulu's Fashion Lounge Holdings, Inc. · May 11, 2023
LM Funding America, Inc. Schedules First Quarter 2023 Financial Results and Business Update Conference Call
LM Funding America, Inc. · May 11, 2023
Live Ventures Reports Fiscal Second Quarter 2023 Financial Results
Live Ventures Incorporated · May 11, 2023
LiqTech International Announces First Quarter 2023 Financial Results
LiqTech International, Inc. · May 11, 2023
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2023
Lipocine Inc. · May 11, 2023
Limoneira Enters into Exclusive Licensing Relationship with Food System Innovation Company Apeel Sciences to Deliver the World’s Best Lemons
Limoneira Co · May 11, 2023
Lightwave Logic Provides First Quarter 2023 Corporate Update
Lightwave Logic, Inc. · May 11, 2023
LightPath Technologies Reports Financial Results for Fiscal 2023 Third Quarter
LightPath Technologies, Inc. · May 11, 2023
Liberty Gold Reports Q1 2023 Financial and Operating Results
Liberty Gold Corp · May 11, 2023
Lexaria Bioscience Announces Closing of $2.0 Million Public Offering
Lexaria Bioscience Corp. · May 11, 2023
Leonardo DRS Recognized With Prestigious Award for Role in Development of Critical Infrared Technology
Leonardo DRS, Inc. · May 11, 2023
Lending Enablement Solutions Drive ROA Attainment for Automotive Lenders, Open Lending Survey Finds
Open Lending Corporation · May 11, 2023
L.B. Foster Company to Present at the Lytham Partners Spring 2023 Virtual Investor Conference on May 18, 2023
L.B. Foster Company · May 11, 2023
Krispy Kreme Reports Strong First Quarter 2023 and Reiterates Full Year Guidance
Krispy Kreme, Inc. · May 11, 2023
Kopin Corporation Reports Financial Results for the First Quarter 2023
Kopin Corporation · May 11, 2023
Kingstone Announces 2023 First Quarter Results
Kingstone Companies, Inc · May 11, 2023
Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
Kezar Life Sciences, Inc. · May 11, 2023
Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association
Keros Therapeutics, Inc. · May 11, 2023
Kelly Reports First-Quarter 2023 Earnings
Kelly Services, Inc. · May 11, 2023
Katapult Announces First Quarter 2023 Financial Results
Katapult Holdings, Inc. · May 11, 2023
Journey Medical Corporation Announces Postponement of First Quarter Financial Results Release and Conference Call
Journey Medical Corporation · May 11, 2023
Jack Henry Executives to Offer Insights at Upcoming Events
Jack Henry & Associates, Inc. · May 11, 2023
Iridex Reports First Quarter 2023 Financial Results
IRIDEX Corporation · May 11, 2023
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
Invivyd, Inc. · May 11, 2023
Intuitive Machines Reports First Quarter 2023 Financial Results
Intuitive Machines, Inc. · May 11, 2023
Intrusion, Inc. Reports First Quarter 2023 Results
Intrusion Inc. · May 11, 2023
Interlink Electronics Reports First Quarter 2023 Results
Interlink Electronics, Inc. · May 11, 2023
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
Intelligent Bio Solutions Inc. · May 11, 2023
Integra LifeSciences Opens New Center of Innovation and Learning
Integra LifeSciences Holdings Corporation · May 11, 2023
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
Instil Bio, Inc. · May 11, 2023
Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon...
QTREX Quantum Ltd. · May 11, 2023
Inotiv, Inc. Announces Second Quarter Fiscal 2023 Financial Results
Inotiv, Inc. · May 11, 2023
Innodata Announces Potentially Transformative Deals in Generative AI with Three of the Largest Global Tech Companies and Reports First Qu...
Innodata Inc. · May 11, 2023
InflaRx Reports First Quarter 2023 Financial and Operating Results and Provides Business Update
InflaRx N.V. · May 11, 2023